Prevalence of vitamin K deficiency in children with mild to moderate chronic liver disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 42, Issue 1, 2006, Pages 71-76

  Mager, Diana R ^a   McGee, Phyllis L ^a   Furuya, Katryn N ^a   Roberts, Eve A ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Children; Cholestatic liver disease; Noncholestatic liver disease; PIVKA II; Vitamin K

Indexed keywords

BILE ACID; BILIRUBIN GLUCURONIDE; BIOLOGICAL MARKER; PROTEIN; PROTHROMBIN; VITAMIN K GROUP;

ADOLESCENT; ARTICLE; BILE ACID BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHILD; CHOLESTASIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFANT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; VITAMIN K DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHOLESTASIS, INTRAHEPATIC; CHRONIC DISEASE; DIETARY FATS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; LIVER DISEASES; MALABSORPTION SYNDROMES; MALE; NUTRITIONAL STATUS; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VITAMIN K; VITAMIN K DEFICIENCY;

EID: 30344438841     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000189327.47150.58     Document Type: Article

References (47)

1. Sokol RJ. Fat-soluble vitamins and their importance in patients with cholestatic liver diseases. Gastroenterol Clin North Am 1994;23:673-705.
2. Lane PA, Hathaway WE. Vitamin K in infancy. J Pediatr 1985;106:351-9.
3. Suchy FJ, ed. Medical and Nutritional Management of Cholestasis. Philadelphia: Lippincott, Williams & Son, 2001.
4. Lipsky JJ. Nutritional sources of vitamin K. Mayo Clin Proc 1994;69:462-6.
5. Bancroft J, Cohen MB. Intracranial hemorrhage due to vitamin K deficiency in breast-fed infants with cholestasis. J Pediatr Gastroenterol Nutr 1993;16:78-80.
6. Binkley NC, Suttie JW. Vitamin K nutrition and osteoporosis. J Nutr 1995;125:1812-21.
7. Hay JE. Bone disease in cholestatic liver disease. Gastroenterology 1995;108:276-83.
8. Sundaram KS, Lev M. Warfarin administration reduces synthesis of sulfatides and other sphingolipids in mouse brain. J Lipid Res 1988;29:1475-9.
9. Shearer MJ. Vitamin K and vitamin K-dependent proteins. Br J Haematol 1990;75:156-62.
10. Motahara KK, Kan H, Endo F, Matsuda I. Detection of vitamin K deficiency by use of an enzyme-linked immunosorbent assay for circulating abnormal prothrombin. Pediatr Res 1985;19:354.
11. von Kries R, Greer FR, Suttie JW. Assessment of vitamin K status of the newborn infant. J Pediatr Gastroenterol Nutr 1993;16:231-8.
12. Sokoll LJ, O'Brien ME, Camilo ME, Sadowski JA. Undercarboxylated osteocalcin and development of a method to determine vitamin K status. Clin Chem 1995;41:1121-8.
13. Rucker RB. Improved functional endpoints for use in vitamin K assessment: important implications for bone disease. Am J Clin Nutr 1997;65:883-4.
14. Sokoll LJ, Booth SL, O'Brien ME, Davidson KW, Tsaioun KI, Sadowski JA. Changes in serum osteocalcin, plasma phylloquinone, and urinary gamma-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. Am J Clin Nutr 1997;65:779-84.
15. Rashid M, Durie P, Andrew M, et al. Prevalence of vitamin K deficiency in cystic fibrosis. Am J Clin Nutr 1999;70:378-82.
16. Wilson DC, Rashid M, Durie PR, et al. Treatment of vitamin K deficiency in cystic fibrosis: effectiveness of a daily fat-soluble vitamin combination. J Pediatr 2001;138:851-5.
17. VanSteenbergen W, Vermylen J. Reversible hypoprothrominemia in a patient with primary biliary cirrhosis treated with rifampicin. Am J Gastroenterol 1995;90.
18. Pereira SP, Shearer MJ, Williams R, Mieli-Vergani G. Intestinal absorption of mixed micellar phylloquinone (vitamin K1) is unreliable in infants with conjugated hyperbilirubinaemia: implications for oral prophylaxis of vitamin K deficiency bleeding. Arch Dis Child Fetal Neonatal Ed 2003;88:F113-18.
19. Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 1987;7:660-4.
20. Child CG, Turcotte JG, ed. Surgery in Portal Hypertension: The Liver and Portal Hypertension. Philadelphia: WB Saunders, 1964.
21. Furuya KN, Durie PR, Roberts EA, et al. Glycine conjugation of para-aminobenzoic acid (PABA): a quantitative test of liver function. Clin Biochem 1995;28:531-40.
22. Saab S, Ibrahim AB, Shpaner A, et al. MELD fails to measure quality of life in liver transplant candidates. Liver Transpl 2005;11:218-23.
23. Farnsworth N, Fagan SP, Berger DH, Awad SS. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg 2004;188:580-3.
24. Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004;40:897-903.
25. Vieira SM, Matte U, Kieling CO, et al. Infected and noninfected ascites in pediatric patients. J Pediatr Gastroenterol Nutr 2005;40:289-94.
26. McDiarmid SV, Anand R, Lindblad AS. Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 2002;74:173-81.
27. Allison PM, Mummah-Schendel LL, Kindberg CG, Harms CS, Bang NU, Suttie JW. Effects of a vitamin K-deficient diet and antibiotics in normal human volunteers. J Lab Clin Med 1987;110:180-8.
28. Lipsky JJ. Antibiotic-associated hypoprothrombinaemia. J Antimicrob Chemother 1988;21:281-300.
29. Shearer MJ, Bechtold H, Andrassy K, et al. Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status. J Clin Pharmacol 1988;28:88-95.
30. Concoran R, Durnan SM. Albumin determination by a modified bromocrescol green method. Clin Chem 1977;23:765.
31. Bretaudiere J. Criteria for establishing a standardized method for determining alkaline phosphatase in serum. Clin Chem 1977;23:2263.
32. Evans LB KR. γ-Glutamyltransferase: response surface co-optimization of reaction conditions with γ-glutamyl-3-carboxy-4- nitroanilide as the substrate 1981;1981;27:1036.
33. Bergmeyer JU, Rej R. Approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase. J Clin Chem Clin Biochem 1986;24:481.
34. Bergmeyer JU, Rej R. Approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 2. IFCC method for aspartate aminotransferase. J Clin Chem Clin Biochem 1986;24:497.
35. Lauff JL KM, Abmrose RT. Separation of Bilirubin species in serum and bile by high-performance reversed phase liquid chromatography. J Chromatograph 1986;226:391-402.
36. Catignani GL BJ. Simultaneous determination of retinol and alpha-tocopheraol in serum or plasma by liquid chromatography. Clin Chem 1983;29:708-12.
37. Cornelissen EA, Kollee LA, van Lith TG, Motohara K, Monnens LA. Evaluation of a daily dose of 25 micrograms vitamin K1 to prevent vitamin K deficiency in breast-fed infants. J Pediatr Gastroenterol Nutr 1993;16:301-5.
38. Fetal and Newborn Committee. The use of vitamin K in the perinatal period. CMAJ 1988;139:127-30.
39. Yanofsky RA, Jackson VG, Lilly JR, Stellin G, Klingensmith WC III, Hathaway WE. The multiple coagulopathies of biliary atresia. Am J Hematol 1984;16:171-80.
40. Kaplan MM, Elta GH, Furie B, Sadowski JA, Russell RM. Fat-soluble vitamin nutriture in primary biliary cirrhosis. Gastroenterology 1988;95:787-92.
41. Kowdley KV, Emond MJ, Sadowski JA, Kaplan MM. Plasma vitamin K1 level is decreased in primary biliary cirrhosis. Am J Gastroenterol 1997;92:2059-61.
42. O'Brien DP, Shearer MJ, Waldron RP, Horgan PG, Given HF. The extent of vitamin K deficiency in patients with cholestatic jaundice: a preliminary communication. J R Soc Med 1994;87:320-2.
43. Aguilar HI RJ, Kodall V, Levis S, et al. Bone disease and plasma vitamin K levels in PBC patients 1993;104:A868.
44. Alvarez F, Cresteil D, Lemonnier F, Lemonnier A, Alagille D. Plasma vitamin E levels in children with cholestasis. J Pediatr Gastroenterol Nutr 1984;3:390-3.
45. Amedee-Manesme O, Furr HC, Alvarez F, Hadchouel M, Alagille D, Olson JA. Biochemical indicators of vitamin A depletion in children with cholestasis. Hepatology 1985;5:1143-8.
46. Mobaharan RR, Underwood BA, et al. Evaluation of the RDR test for vitamin A nutriture in cirrhotics. Am J Clin Nutr 1981;34:1147-8.
47. Balthazor M RE, Barkas L, Ng VL. Delayed developmental outcome in poster in children with extraheptaic biliary atresia. J Pediatr Gastroenterol Nutr 2003;3:344A.